Literature DB >> 23123251

Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects.

Galina F Makhaeva1, Eugene V Radchenko, Vladimir A Palyulin, Elena V Rudakova, Alexey Yu Aksinenko, Vladimir B Sokolov, Nikolay S Zefirov, Rudy J Richardson.   

Abstract

Certain organophosphorus compounds (OPCs) inhibit various serine esterases (EOHs) via phosphorylation of their active site serines. We focused on 4 EOHs of particular toxicological interest: acetylcholinesterase (AChE: acute neurotoxicity; cognition enhancement), butyrylcholinesterase (BChE: inhibition of drug metabolism and/or stoichiometric scavenging of EOH inhibitors; cognition enhancement), carboxylesterase (CaE: inhibition of drug metabolism and/or stoichiometric scavenging of EOH inhibitors), and neuropathy target esterase (NTE: delayed neurotoxicity, OPIDN). The relative degree of inhibition of these EOHs constitutes the "esterase profile" of an OPC and serves as a major determinant of its net physiological effects. Thus, understanding and controlling the esterase profile of OPC activity and selectivity toward these 4 target enzymes is a significant undertaking. In the present study, we analyzed the inhibitor properties of 52 OPCs against the 4 EOHs, along with pairwise and multitarget selectivities between them, using 2 QSAR approaches: Hansch modeling and Molecular Field Topology Analysis (MFTA). The general formula of the OPCs was (RO)(2)P(O)X, where R = alkyl, X = - SCH(Hal)COOEt (Hal = Cl, Br), -SCHCl(2), -SCH(2)Br, -OCH(CF(3))R(1) (R(1) = C(6)H(5), CF(3), COOEt, COOMe). The Hansch model showed that increasing neuropathic potential correlated with rising R hydrophobicity; moreover, OPC binding to scavenger EOHs (BChE and CaE) had different effects on potential acute and delayed neurotoxicity. Predicted protective roles of BChE and CaE against acute toxicity were enhanced with increasing hydrophobicity, but projected protection against OPIDN was decreased. Next, Molecular Field Topology Analysis (MFTA) models were built, considering atomic descriptors, e.g., effective charge, van der Waals radius of environment, and group lipophilicity. Activity/selectivity maps confirmed predictions from Hansch models and revealed other structural factors affecting activity and selectivity. Virtual screening based on multitarget selectivity MFTA models was used to design libraries of OPCs with favorable esterase profiles for potential application as selective inhibitors of CaE without untoward side effects.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123251     DOI: 10.1016/j.cbi.2012.10.012

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  14 in total

1.  Kinetics and mechanism of inhibition of serine esterases by fluorinated carbethoxy 1-aminophosphonates.

Authors:  G F Makhaeva; S V Lushchekina; O G Serebryakova; A Yu Aksinenko; T V Goreva; R J Richardson; I V Martynov
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

2.  N,N-disubstituted 2-aminothiazolines as new inhibitors of serine esterases.

Authors:  N P Boltneva; O G Serebryakova; G F Makhaeva; I V Serkov; A N Proshin; S O Bachurin
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

3.  Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.

Authors:  Galina F Makhaeva; Elena V Rudakova; Nichole D Hein; Olga G Serebryakova; Nadezhda V Kovaleva; Natalia P Boltneva; John K Fink; Rudy J Richardson
Journal:  J Appl Toxicol       Date:  2014-01-07       Impact factor: 3.446

Review 4.  In Silico Models for Predicting Acute Systemic Toxicity.

Authors:  Ivanka Tsakovska; Antonia Diukendjieva; Andrew P Worth
Journal:  Methods Mol Biol       Date:  2022

5.  Modeling in vitro inhibition of butyrylcholinesterase using molecular docking, multi-linear regression and artificial neural network approaches.

Authors:  Fang Zheng; Max Zhan; Xiaoqin Huang; Mohamed Diwan M Abdul Hameed; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2013-11-08       Impact factor: 3.641

6.  Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.

Authors:  Sergey O Bachurin; Elena F Shevtsova; Galina F Makhaeva; Vladimir V Grigoriev; Natalia P Boltneva; Nadezhda V Kovaleva; Sofya V Lushchekina; Pavel N Shevtsov; Margarita E Neganova; Olga M Redkozubova; Elena V Bovina; Alexey V Gabrelyan; Vladimir P Fisenko; Vladimir B Sokolov; Alexey Yu Aksinenko; Valentina Echeverria; George E Barreto; Gjumrakch Aliev
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

Review 7.  The Axon-Myelin Unit in Development and Degenerative Disease.

Authors:  Ruth M Stassart; Wiebke Möbius; Klaus-Armin Nave; Julia M Edgar
Journal:  Front Neurosci       Date:  2018-07-11       Impact factor: 4.677

8.  Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.

Authors:  Sergey O Bachurin; Galina F Makhaeva; Elena F Shevtsova; Natalia P Boltneva; Nadezhda V Kovaleva; Sofya V Lushchekina; Elena V Rudakova; Ludmila G Dubova; Daria V Vinogradova; Vladimir B Sokolov; Alexey Yu Aksinenko; Vladimir P Fisenko; Rudy J Richardson; Gjumrakch Aliev
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

9.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03

10.  Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.

Authors:  Galina F Makhaeva; Sofya V Lushchekina; Natalia P Boltneva; Vladimir B Sokolov; Vladimir V Grigoriev; Olga G Serebryakova; Ekaterina A Vikhareva; Alexey Yu Aksinenko; George E Barreto; Gjumrakch Aliev; Sergey O Bachurin
Journal:  Sci Rep       Date:  2015-08-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.